Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

NCT03055494 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

BIOLOGICAL: Secukinumab
BIOLOGICAL: Placebo

Sponsor

Novartis Pharmaceuticals